The excessive loading of BRD4 and mediators at SE sites linked to MYC and other lineage-specific survival genes may be preferentially replaced by JQ1, which would explain why JQ1 is insensitive to MM treatment [114]. This evidence concerns the gene BRD4 and Miyoshi myopathy.